Stonegate Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Sell |
6,142
-214
| -3% | -$95.3K | 0.07% | 112 |
|
|
2025
Q1 | $3.08M | Sell |
6,356
-153
| -2% | -$74.2K | 0.08% | 93 |
|
|
2024
Q4 | $2.62M | Buy |
6,509
+41
| +0.6% | +$16.5K | 0.07% | 105 |
|
|
2024
Q3 | $3.01M | Sell |
6,468
-274
| -4% | -$127K | 0.08% | 95 |
|
|
2024
Q2 | $3.16M | Buy |
6,742
+3,598
| +114% | +$1.69M | 0.09% | 89 |
|
|
2024
Q1 | $1.31M | Sell |
3,144
-132
| -4% | -$55.2K | 0.04% | 142 |
|
|
2023
Q4 | $1.33M | Sell |
3,276
-154
| -4% | -$62.7K | 0.04% | 141 |
|
|
2023
Q3 | $1.19M | Sell |
3,430
-392
| -10% | -$136K | 0.04% | 142 |
|
|
2023
Q2 | $1.35M | Sell |
3,822
-3
| -0.1% | -$1.06K | 0.05% | 139 |
|
|
2023
Q1 | $1.21M | Sell |
3,825
-470
| -11% | -$148K | 0.05% | 143 |
|
|
2022
Q4 | $1.24M | Sell |
4,295
-44
| -1% | -$12.7K | 0.05% | 123 |
|
|
2022
Q3 | $1.26M | Sell |
4,339
-370
| -8% | -$107K | 0.06% | 123 |
|
|
2022
Q2 | $1.33M | Sell |
4,709
-494
| -9% | -$139K | 0.06% | 128 |
|
|
2022
Q1 | $1.36M | Sell |
5,203
-544
| -9% | -$142K | 0.04% | 116 |
|
|
2021
Q4 | $1.26M | Buy |
+5,747
| New | +$1.26M | 0.05% | 119 |
|